Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
Eur Rev Med Pharmacol Sci ; 25(8): 3316-3324, 2021 04.
Artigo em Inglês | MEDLINE | ID: mdl-33928619

RESUMO

OBJECTIVE: This open-label non-randomized clinical study aimed at evaluating the effects of myo-inositol plus alpha-lactalbumin in two groups of PCOS women, treated in Mexico and Italy. Alpha-lactalbumin was used being effective in increasing myo-inositol intestinal absorption. This effect is very useful in greatly reducing the therapeutic failure of myo-inositol in some patients (inositol resistant subjects). PATIENTS AND METHODS: The study involved 34 normal weight or overweight patients (14 in Mexico and 20 in Italy), aged 18 to 40 years, with anovulation and infertility > 1 year and insulin resistance diagnosed by HOMA-Index. Patients were administered orally with 2 g myo-inositol, 50 mg alpha-lactalbumin, and 200 µg of folic acid twice a day for 6 months. Controls were the same patients at t0 (baseline). The primary outcome was HOMA-index decrease after 3 and 6 months of treatment. Other parameters monitored were BMI, progesterone, LH, FSH, total testosterone, free testosterone, androstenedione, total cholesterol, HDL, LDL, triglycerides. RESULTS: Recovery was general, and its relevance was higher when the starting point was further away from the normal range. The most important results were obtained with insulin, HOMA-index, LH, and androstenedione. No significant adverse effects were detected in both groups of patients. CONCLUSIONS: This clinical trial demonstrated for the first time that myo-inositol and alpha-lactalbumin improve important parameters in PCOS patients characterized by different metabolic profiles.


Assuntos
Inositol/uso terapêutico , Lactalbumina/uso terapêutico , Síndrome do Ovário Policístico/tratamento farmacológico , Adolescente , Adulto , Feminino , Humanos , Itália , México , Sobrepeso/tratamento farmacológico , Adulto Jovem
2.
Arq Gastroenterol ; 21(3): 130-5, 1984.
Artigo em Inglês | MEDLINE | ID: mdl-6442856

RESUMO

Thirty-eight moderately to severely malnourished children with severe acute or subacute diarrhea were treated according to two different feeding schemes, divided at random half of the children received semi-elemental diet (SED) with an osmolarity of 302 milliosmol per liter, a low lactose content and a relatively high content of lactalbumine hydrolysate (1 g/100 ml). The other half of the patients received available proprietory formulas or diluted cow's milk with added carbohydrates. The results obtained showed that the children who were fed the SED had a better average weight gain during the first three weeks of hospitalization compared to the control group. The children receiving the SED also required a smaller number or rehydrations.


Assuntos
Diarreia Infantil/dietoterapia , Alimentos Formulados , Desnutrição Proteico-Calórica/dietoterapia , Doença Aguda , Animais , Peso Corporal , Bovinos , Feminino , Humanos , Lactente , Lactalbumina/uso terapêutico , Tempo de Internação , Masculino , Leite , Concentração Osmolar , Hidrolisados de Proteína/uso terapêutico , Desnutrição Proteico-Calórica/fisiopatologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA